Proteina spike ricombinante sars-cov-2 con adiuvante matrix-m

Classification

1. Anatomical main groupJAnti-infectives for systemic use
2. Therapeutic subgroupJ07
3. Pharmacological subgroupJ07B
4. Chemical subgroupJ07BN
5. Chemical substanceJ07BN04Covid-19, protein subunit

Where it is registered

Each register with its number of medicines and a few of them.

• 🇮🇹Italy

  AIFA · 2 medicines

  • Nuvaxovid JN.1Dispersione per preparazione iniettabile · Sanofi Winthrop Industrie
  • Nuvaxovid XFGDispersione per preparazione iniettabile · Sanofi Winthrop Industrie

All medicines with Proteina spike ricombinante sars-cov-2 con adiuvante matrix-m

Every register, a page at a time. Strengths and packs are on each medicine’s page.